Show simple item record

Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

dc.contributor.authorULUSOY, CANAN AYSEL
dc.date.accessioned2021-03-03T12:36:14Z
dc.date.available2021-03-03T12:36:14Z
dc.identifier.citationULUSOY C. A. , "Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients", 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Danimarka, ss.450
dc.identifier.othervv_1032021
dc.identifier.otherav_2f05495f-8660-4017-8260-ae1825318d87
dc.identifier.urihttp://hdl.handle.net/20.500.12627/36136
dc.language.isoeng
dc.subjectSosyal ve Beşeri Bilimler
dc.subjectDavranış Bilimleri
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.titleReduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , Aziz Sancar Deneysel Tıp Araştırma Enstitüsü , Sinir Bilimi Ana Bilim Dalı
dc.contributor.firstauthorID408614


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record